Mikhail Blagosklonny is a well-respected scientist who is changing the lives of numerous patients in the oncology department. The scientist is well educated and experienced, having attended some of the best learning institutions in the United States. According to his portfolio, the scientist acquired his doctor of medicine specializing in internal medicine. The scientist has a Ph.D. in experimental medicine which was acquired from an institution known as First Pavlov State Medical University. Mikhail has had the opportunity of working with some of the leading institutions in America, acquiring a lot of expertise. His skills enabled him to acquire a position at an institution called Roswell Park Cancer Institute. His input in the organization has been felt for several years now. Follow Mikhail on Google Scholar.
Doctors have been doing their best to come up with the right cure for the people living with different types of cancers. Despite the numerous advancements made by people in the field, people are still losing their lives due to cancer. Cancer has become a killer in most nations of the world. Doctors and the medical community are worried by the increasing number of people living with the medical condition. Very few people can access the right form of treatment with the limited resources and few options available for cancer patients. Medical professionals have no choice but to rely on the expertise advice they get from scientists such as Mikhail Blagosklonny. The businessman has introduced a new form of treatment for cancer patients.
Just recently, Mikhail Blagosklonny published research on the use of a drug known as Rapamycin for the treatment of cancer and reversing the effects of aging on the communities. According to Mikhail, this form of a drug will have numerous benefits to the medical community. Apart from being an effective cure for cancer patients, individuals who have undergone any form of transplant can rely on the drug because of its healing properties. The scientist has also explained to the world about the relationship that exists between cancer and anti-aging.
Apart from his significant input in the oncology department, the businessman is the chief editor for one of the top scientific journals in the world, known as Oncotarget. The journal was only launched into the market several years ago, and it has been able to assist the community to access information concerning cancer and other forms of ailments affecting the modern generation. Oncotarget has won several awards in the recent times because of its contributions to the oncology department. Read more about Mikhail on Crunchbase.